{"transactions":[{"id":808429,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-04-15T20:20:42.000Z","date":"2026-04-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1069,"price":4.91,"value":5248.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on April 14, 2026."}],"balance_after":629646,"source":{"system":"sec-edgar","filing":"0001517026-26-000008","document":"wk-form4_1776284439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000008/wk-form4_1776284439.xml","form_type":"4"}},{"id":831492,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-23T20:22:58.000Z","date":"2026-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2055,"price":4.58,"value":9411.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 20, 2026."}],"balance_after":630715,"source":{"system":"sec-edgar","filing":"0001517026-26-000006","document":"wk-form4_1774297376.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000006/wk-form4_1774297376.xml","form_type":"4"}},{"id":842660,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:40.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":9096,"price":4.66,"value":42387.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of the Issuer's Common Stock on March 13, 2026."}],"balance_after":632770,"source":{"system":"sec-edgar","filing":"0001517026-26-000004","document":"wk-form4_1773695137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000004/wk-form4_1773695137.xml","form_type":"4"}},{"id":842659,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:40.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":5611,"price":4.66,"value":26147.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":641866,"source":{"system":"sec-edgar","filing":"0001517026-26-000004","document":"wk-form4_1773695137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000004/wk-form4_1773695137.xml","form_type":"4"}},{"id":842658,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:40.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":5418,"price":4.66,"value":25247.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":647477,"source":{"system":"sec-edgar","filing":"0001517026-26-000004","document":"wk-form4_1773695137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000004/wk-form4_1773695137.xml","form_type":"4"}},{"id":842657,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:40.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":9164,"price":4.66,"value":42704.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":652895,"source":{"system":"sec-edgar","filing":"0001517026-26-000004","document":"wk-form4_1773695137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000004/wk-form4_1773695137.xml","form_type":"4"}},{"id":842656,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:05:40.000Z","date":"2026-03-12","kind":"grant","planned":false,"acquired":true,"shares":247423,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":662059,"source":{"system":"sec-edgar","filing":"0001517026-26-000004","document":"wk-form4_1773695137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000004/wk-form4_1773695137.xml","form_type":"4"}},{"id":922972,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-03T22:30:09.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":32810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026."}],"balance_after":414636,"source":{"system":"sec-edgar","filing":"0001517026-26-000002","document":"wk-form4_1770157806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702626000002/wk-form4_1770157806.xml","form_type":"4"}},{"id":1035128,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-09-22T20:16:22.000Z","date":"2025-09-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1085,"price":7.77,"value":8430.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 19, 2025."}],"balance_after":381826,"source":{"system":"sec-edgar","filing":"0001517026-25-000008","document":"wk-form4_1758572179.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702625000008/wk-form4_1758572179.xml","form_type":"4"}},{"id":1162823,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2025-05-01T20:27:14.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":105785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares subject to the performance-based restricted stock units (\"PSUs\") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the performance-based restricted stock units (\"PSUs\") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares subject to the performance-based restricted stock units (\"PSUs\") represent the maximum number of shares that may vest based on the Issuer's achievement of specified stock price milestones. The PSUs will vest upon certification by the Compensation and Human Capital Committee as to 25% of the shares upon the achievement of each of four stock price milestones, subject to the reporting person's continued employment or service through the applicable vesting date; provided; however, that no portion of the PSUs may vest earlier than April 30, 2026."}],"balance_after":105785,"derivative":{"underlying":"Common Stock","underlying_shares":105785},"source":{"system":"sec-edgar","filing":"0001517026-25-000005","document":"wk-form4_1746131228.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702625000005/wk-form4_1746131228.xml","form_type":"4"}},{"id":1172161,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-04-15T20:12:34.000Z","date":"2025-04-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1085,"price":8.08,"value":8766.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 14, 2025."}],"balance_after":382911,"source":{"system":"sec-edgar","filing":"0001517026-25-000002","document":"wk-form4_1744747947.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702625000002/wk-form4_1744747947.xml","form_type":"4"}},{"id":1192718,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:16:39.000Z","date":"2025-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1605,"price":9.98,"value":16017.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025."}],"balance_after":383996,"source":{"system":"sec-edgar","filing":"0001628280-25-014724","document":"wk-form4_1742933792.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014724/wk-form4_1742933792.xml","form_type":"4"}},{"id":1192717,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:16:39.000Z","date":"2025-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1096,"price":9.98,"value":10938.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025."}],"balance_after":385601,"source":{"system":"sec-edgar","filing":"0001628280-25-014724","document":"wk-form4_1742933792.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014724/wk-form4_1742933792.xml","form_type":"4"}},{"id":1192716,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:16:39.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":3623,"price":10.01,"value":36266.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":386697,"source":{"system":"sec-edgar","filing":"0001628280-25-014724","document":"wk-form4_1742933792.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014724/wk-form4_1742933792.xml","form_type":"4"}},{"id":1192715,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:16:39.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1366,"price":10.01,"value":13673.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":390320,"source":{"system":"sec-edgar","filing":"0001628280-25-014724","document":"wk-form4_1742933792.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014724/wk-form4_1742933792.xml","form_type":"4"}},{"id":1204837,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-17T20:19:34.000Z","date":"2025-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3729,"price":10.07,"value":37551.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025."}],"balance_after":391686,"source":{"system":"sec-edgar","filing":"0001628280-25-013145","document":"wk-form4_1742242769.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025013145/wk-form4_1742242769.xml","form_type":"4"}},{"id":1204836,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-17T20:19:34.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":5847,"price":10.07,"value":58879.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025."}],"balance_after":395415,"source":{"system":"sec-edgar","filing":"0001628280-25-013145","document":"wk-form4_1742242769.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025013145/wk-form4_1742242769.xml","form_type":"4"}},{"id":1204835,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-17T20:19:34.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":99227,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":401262,"source":{"system":"sec-edgar","filing":"0001628280-25-013145","document":"wk-form4_1742242769.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025013145/wk-form4_1742242769.xml","form_type":"4"}},{"id":1232254,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T00:31:21.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":12758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) initially granted on March 22, 2022, subject to accomplishment of pre-determined performance metrics. On February 7, 2025, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 22, 2025."}],"balance_after":302035,"source":{"system":"sec-edgar","filing":"0001628280-25-010136","document":"wk-form4_1741134675.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025010136/wk-form4_1741134675.xml","form_type":"4"}},{"id":1388309,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-10T20:36:13.000Z","date":"2024-10-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":5004,"price":24.37,"value":121947.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2024."}],"balance_after":289277,"source":{"system":"sec-edgar","filing":"0001517026-24-000006","document":"wk-form4_1728592566.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702624000006/wk-form4_1728592566.xml","form_type":"4"}},{"id":1388308,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-10T20:36:13.000Z","date":"2024-10-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":3359,"price":24.37,"value":81858.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2024."}],"balance_after":294281,"source":{"system":"sec-edgar","filing":"0001517026-24-000006","document":"wk-form4_1728592566.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702624000006/wk-form4_1728592566.xml","form_type":"4"}},{"id":1401199,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-23T20:21:06.000Z","date":"2024-09-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1075,"price":27.64,"value":29713.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 20, 2024."}],"balance_after":297640,"source":{"system":"sec-edgar","filing":"0001517026-24-000004","document":"wk-form4_1727122860.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702624000004/wk-form4_1727122860.xml","form_type":"4"}},{"id":1542215,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-04-15T20:25:27.000Z","date":"2024-04-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1076,"price":19.55,"value":21035.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 12, 2024."}],"balance_after":298715,"source":{"system":"sec-edgar","filing":"0001517026-24-000002","document":"wk-form4_1713212713.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702624000002/wk-form4_1713212713.xml","form_type":"4"}},{"id":1562545,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-25T20:31:01.000Z","date":"2024-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1584,"price":22.24,"value":35228.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024."}],"balance_after":299791,"source":{"system":"sec-edgar","filing":"0001628280-24-012915","document":"wk-form4_1711398651.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024012915/wk-form4_1711398651.xml","form_type":"4"}},{"id":1562544,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-25T20:31:01.000Z","date":"2024-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1661,"price":22.24,"value":36940.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024."}],"balance_after":301375,"source":{"system":"sec-edgar","filing":"0001628280-24-012915","document":"wk-form4_1711398651.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024012915/wk-form4_1711398651.xml","form_type":"4"}},{"id":1562543,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-25T20:31:01.000Z","date":"2024-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1648,"price":22.24,"value":36651.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024."}],"balance_after":303036,"source":{"system":"sec-edgar","filing":"0001628280-24-012915","document":"wk-form4_1711398651.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024012915/wk-form4_1711398651.xml","form_type":"4"}},{"id":1573558,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-18T20:45:13.000Z","date":"2024-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3686,"price":21.16,"value":77995.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 15, 2024."}],"balance_after":304684,"source":{"system":"sec-edgar","filing":"0001628280-24-011681","document":"wk-form4_1710794695.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024011681/wk-form4_1710794695.xml","form_type":"4"}},{"id":1573557,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-18T20:45:13.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":58631,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":308370,"source":{"system":"sec-edgar","filing":"0001628280-24-011681","document":"wk-form4_1710794695.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024011681/wk-form4_1710794695.xml","form_type":"4"}},{"id":1762973,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-10-10T20:21:03.000Z","date":"2023-10-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":5006,"price":15.01,"value":75140.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2023."}],"balance_after":249739,"source":{"system":"sec-edgar","filing":"0001517026-23-000009","document":"wk-form4_1696969253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702623000009/wk-form4_1696969253.xml","form_type":"4"}},{"id":1762972,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-10-10T20:21:03.000Z","date":"2023-10-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":3360,"price":15.01,"value":50433.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2023."}],"balance_after":254745,"source":{"system":"sec-edgar","filing":"0001517026-23-000009","document":"wk-form4_1696969253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702623000009/wk-form4_1696969253.xml","form_type":"4"}},{"id":1772858,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-09-27T20:30:31.000Z","date":"2023-09-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":3523,"price":15.99,"value":56332.77,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 26, 2023."}],"balance_after":258105,"source":{"system":"sec-edgar","filing":"0001517026-23-000007","document":"wk-form4_1695846619.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702623000007/wk-form4_1695846619.xml","form_type":"4"}},{"id":1775054,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-09-22T20:26:39.000Z","date":"2023-09-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1076,"price":16.77,"value":18044.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 21, 2023."}],"balance_after":261628,"source":{"system":"sec-edgar","filing":"0001517026-23-000005","document":"wk-form4_1695414390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702623000005/wk-form4_1695414390.xml","form_type":"4"}},{"id":1919197,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-04-17T22:22:55.000Z","date":"2023-04-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":703,"price":22.27,"value":15655.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 14, 2023."}],"balance_after":262704,"source":{"system":"sec-edgar","filing":"0001517026-23-000002","document":"wf-form4_168177016388393.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702623000002/wf-form4_168177016388393.xml","form_type":"4"}},{"id":1938399,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-27T20:27:56.000Z","date":"2023-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1586,"price":23.72,"value":37619.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023."}],"balance_after":263407,"source":{"system":"sec-edgar","filing":"0001628280-23-009262","document":"wf-form4_167994886476875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023009262/wf-form4_167994886476875.xml","form_type":"4"}},{"id":1938398,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-27T20:27:56.000Z","date":"2023-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1083,"price":23.72,"value":25688.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023."}],"balance_after":264993,"source":{"system":"sec-edgar","filing":"0001628280-23-009262","document":"wf-form4_167994886476875.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023009262/wf-form4_167994886476875.xml","form_type":"4"}},{"id":1940671,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-23T20:28:35.000Z","date":"2023-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1351,"price":22.91,"value":30951.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023."}],"balance_after":266076,"source":{"system":"sec-edgar","filing":"0001628280-23-009049","document":"wf-form4_167960329972877.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023009049/wf-form4_167960329972877.xml","form_type":"4"}},{"id":1950937,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-16T20:29:29.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":39405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":267427,"source":{"system":"sec-edgar","filing":"0001628280-23-008316","document":"wf-form4_167899855540034.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023008316/wf-form4_167899855540034.xml","form_type":"4"}},{"id":2139696,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-10-11T20:35:27.000Z","date":"2022-10-09","kind":"tax_withholding","acquired":false,"shares":5006,"price":19.62,"value":98217.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 7, 2022."}],"balance_after":228022,"source":{"system":"sec-edgar","filing":"0001628280-22-026252","document":"wf-form4_166552048411646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022026252/wf-form4_166552048411646.xml","form_type":"4"}},{"id":2139695,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-10-11T20:35:27.000Z","date":"2022-10-09","kind":"tax_withholding","acquired":false,"shares":3360,"price":19.62,"value":65923.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 7, 2022."}],"balance_after":233028,"source":{"system":"sec-edgar","filing":"0001628280-22-026252","document":"wf-form4_166552048411646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022026252/wf-form4_166552048411646.xml","form_type":"4"}},{"id":2150765,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-09-27T20:32:08.000Z","date":"2022-09-26","kind":"tax_withholding","acquired":false,"shares":2293,"price":18.41,"value":42214.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 26, 2022."}],"balance_after":236388,"source":{"system":"sec-edgar","filing":"0001628280-22-025565","document":"wf-form4_166431070757532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022025565/wf-form4_166431070757532.xml","form_type":"4"}},{"id":2150764,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-09-27T20:32:08.000Z","date":"2022-09-25","kind":"tax_withholding","acquired":false,"shares":2793,"price":18.69,"value":52201.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 23, 2022."}],"balance_after":238681,"source":{"system":"sec-edgar","filing":"0001628280-22-025565","document":"wf-form4_166431070757532.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022025565/wf-form4_166431070757532.xml","form_type":"4"}},{"id":2153005,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-09-22T20:38:56.000Z","date":"2022-09-21","kind":"tax_withholding","acquired":false,"shares":702,"price":20.2,"value":14180.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 21, 2022."}],"balance_after":241474,"source":{"system":"sec-edgar","filing":"0001517026-22-000009","document":"wf-form4_166387912215433.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702622000009/wf-form4_166387912215433.xml","form_type":"4"}},{"id":2173331,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-08-26T20:23:26.000Z","date":"2022-08-25","kind":"tax_withholding","acquired":false,"shares":1031,"price":24.89,"value":25661.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 25, 2022."}],"balance_after":242176,"source":{"system":"sec-edgar","filing":"0001628280-22-023770","document":"wf-form4_166154538405411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022023770/wf-form4_166154538405411.xml","form_type":"4"}},{"id":2297320,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-04-14T21:00:53.000Z","date":"2022-04-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":243207,"source":{"system":"sec-edgar","filing":"0001517026-22-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702622000008/edgardoc.xml","form_type":"4"}},{"id":2318211,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mental Health"}}],"security":"Common Stock","published_at":"2022-03-25T21:06:55.000Z","date":"2022-03-24","kind":"tax_withholding","acquired":false,"shares":1584,"price":25.32,"value":40106.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022."}],"balance_after":233207,"source":{"system":"sec-edgar","filing":"0001517026-22-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702622000006/edgardoc.xml","form_type":"4"}},{"id":2318210,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mental Health"}}],"security":"Common Stock","published_at":"2022-03-25T21:06:55.000Z","date":"2022-03-24","kind":"tax_withholding","acquired":false,"shares":1082,"price":25.32,"value":27396.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2022."}],"balance_after":234791,"source":{"system":"sec-edgar","filing":"0001517026-22-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702622000006/edgardoc.xml","form_type":"4"}},{"id":2320467,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mental Health"}}],"security":"Common Stock","published_at":"2022-03-23T20:52:25.000Z","date":"2022-03-22","kind":"grant","acquired":true,"shares":19238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":235873,"source":{"system":"sec-edgar","filing":"0001517026-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702622000004/edgardoc.xml","form_type":"4"}},{"id":2386449,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Mental Health"}}],"security":"Common Stock","published_at":"2022-02-18T22:11:14.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":22616,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on March 24, 2021, subject to accomplishment of pre-determined performance metrics.  On February 16, 2022, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics.  Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on March 24, 2022, 25% on March 24, 2023, 25% on March 24, 2024, and 25% on March 24, 2025."}],"balance_after":216635,"source":{"system":"sec-edgar","filing":"0001517026-22-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702622000002/edgardoc.xml","form_type":"4"}},{"id":2544937,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Myriad Neuroscience"}}],"security":"Common Stock","published_at":"2021-10-12T20:55:55.000Z","date":"2021-10-09","kind":"tax_withholding","acquired":false,"shares":4991,"price":30.88,"value":154122.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock October 8, 2021."}],"balance_after":194019,"source":{"system":"sec-edgar","filing":"0001517026-21-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702621000009/edgardoc.xml","form_type":"4"}},{"id":2544936,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Myriad Neuroscience"}}],"security":"Common Stock","published_at":"2021-10-12T20:55:55.000Z","date":"2021-10-09","kind":"tax_withholding","acquired":false,"shares":3349,"price":30.88,"value":103417.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 8, 2021."}],"balance_after":199010,"source":{"system":"sec-edgar","filing":"0001517026-21-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702621000009/edgardoc.xml","form_type":"4"}},{"id":2559325,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Myriad Neuroscience"}}],"security":"Common Stock","published_at":"2021-09-28T01:12:04.000Z","date":"2021-09-26","kind":"tax_withholding","acquired":false,"shares":3514,"price":33.31,"value":117051.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021."}],"balance_after":202359,"source":{"system":"sec-edgar","filing":"0001517026-21-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702621000007/edgardoc.xml","form_type":"4"}},{"id":2559324,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Myriad Neuroscience"}}],"security":"Common Stock","published_at":"2021-09-28T01:12:04.000Z","date":"2021-09-25","kind":"tax_withholding","acquired":false,"shares":6746,"price":33.31,"value":224709.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 24, 2021."}],"balance_after":205873,"source":{"system":"sec-edgar","filing":"0001517026-21-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702621000007/edgardoc.xml","form_type":"4"}},{"id":2561262,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Myriad Neuroscience"}}],"security":"Common Stock","published_at":"2021-09-23T21:22:28.000Z","date":"2021-09-21","kind":"grant","acquired":true,"shares":46571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on October 8, 2020, subject to accomplishment of pre-determined performance metrics.  On September 21, 2021, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics.  Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024."}],"balance_after":212619,"source":{"system":"sec-edgar","filing":"0001517026-21-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702621000005/edgardoc.xml","form_type":"4"}},{"id":2561261,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Myriad Neuroscience"}}],"security":"Common Stock","published_at":"2021-09-23T21:22:28.000Z","date":"2021-09-21","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":166048,"source":{"system":"sec-edgar","filing":"0001517026-21-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702621000005/edgardoc.xml","form_type":"4"}},{"id":2590049,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Myriad Neuroscience"}}],"security":"Common Stock","published_at":"2021-08-27T01:55:10.000Z","date":"2021-08-25","kind":"tax_withholding","acquired":false,"shares":1082,"price":34.81,"value":37664.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on August 25, 2021."}],"balance_after":156048,"source":{"system":"sec-edgar","filing":"0001517026-21-000003","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702621000003/edgardoc.xml","form_type":"4"}},{"id":2771106,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Myriad Neuroscience"}}],"security":"Common Stock","published_at":"2021-03-26T20:23:28.000Z","date":"2021-03-24","kind":"grant","acquired":true,"shares":15441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":157130,"source":{"system":"sec-edgar","filing":"0001517026-21-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702621000002/edgardoc.xml","form_type":"4"}},{"id":3008749,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Assurex Health Inc."}}],"security":"Common Stock","published_at":"2020-10-13T12:11:04.000Z","date":"2020-10-08","kind":"grant","acquired":true,"shares":31258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on October 9, 2021, 25% on October 9, 2022, 25% on October 9, 2023, and 25% on October 9, 2024."}],"balance_after":141689,"source":{"system":"sec-edgar","filing":"0001517026-20-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702620000008/edgardoc.xml","form_type":"4"}},{"id":3019135,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Assurex Health Inc."}}],"security":"Common Stock","published_at":"2020-10-01T21:35:43.000Z","date":"2020-09-30","kind":"disposition_to_issuer","acquired":false,"shares":725,"price":13.04,"value":9454.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":110431,"source":{"system":"sec-edgar","filing":"0001517026-20-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702620000006/edgardoc.xml","form_type":"4"}},{"id":3021916,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Assurex Health Inc."}}],"security":"Common Stock","published_at":"2020-09-28T16:55:34.000Z","date":"2020-09-26","kind":"disposition_to_issuer","acquired":false,"shares":2376,"price":12.44,"value":29557.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance stock units granted to the reporting person."}],"balance_after":111156,"source":{"system":"sec-edgar","filing":"0001517026-20-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702620000004/edgardoc.xml","form_type":"4"}},{"id":3021915,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Assurex Health Inc."}}],"security":"Common Stock","published_at":"2020-09-28T16:55:34.000Z","date":"2020-09-25","kind":"disposition_to_issuer","acquired":false,"shares":2897,"price":12.44,"value":36038.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":113532,"source":{"system":"sec-edgar","filing":"0001517026-20-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702620000004/edgardoc.xml","form_type":"4"}},{"id":3021914,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Assurex Health Inc."}}],"security":"Common Stock","published_at":"2020-09-28T16:55:34.000Z","date":"2020-09-25","kind":"disposition_to_issuer","acquired":false,"shares":2897,"price":12.44,"value":36038.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":116429,"source":{"system":"sec-edgar","filing":"0001517026-20-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702620000004/edgardoc.xml","form_type":"4"}},{"id":3021913,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Assurex Health Inc."}}],"security":"Common Stock","published_at":"2020-09-28T16:55:34.000Z","date":"2020-09-24","kind":"grant","acquired":true,"shares":32800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of performance stock units granted pursuant to the Companys 2017 Employee, Director and Consultant Equity Incentive Plan.  Performance stock units initially granted on September 25, 2019, subject to accomplishment of pre-determined financial performance requirements.  On September 24, 2020, the Compensation Committee determined the final award amount based on the accomplishment of the applicable financial performance requirements.  Each performance stock unit represents a contingent right to receive one share of the Companys common stock, and vests 25% on September 26, 2020, 25% on September 26, 2021, 25% on September 26, 2022, and 25% on September 26, 2023."}],"balance_after":119326,"source":{"system":"sec-edgar","filing":"0001517026-20-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702620000004/edgardoc.xml","form_type":"4"}},{"id":3056443,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Assurex Health Inc."}}],"security":"Common Stock","published_at":"2020-08-17T20:29:27.000Z","date":"2020-08-12","kind":"grant","acquired":true,"shares":7467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 50% on August 25, 2021, and 50% on August 25, 2022."}],"balance_after":86526,"source":{"system":"sec-edgar","filing":"0001517026-20-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702620000002/edgardoc.xml","form_type":"4"}},{"id":3403671,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Assurex Health Inc."}}],"security":"Common Stock","published_at":"2019-10-01T22:37:06.000Z","date":"2019-09-30","kind":"disposition_to_issuer","acquired":false,"shares":725,"price":28.63,"value":20756.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":79059,"source":{"system":"sec-edgar","filing":"0001517026-19-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702619000004/edgardoc.xml","form_type":"4"}},{"id":3406016,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Assurex Health Inc."}}],"security":"Common Stock","published_at":"2019-09-26T21:06:44.000Z","date":"2019-09-25","kind":"disposition_to_issuer","acquired":false,"shares":2897,"price":29.93,"value":86707.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":79784,"source":{"system":"sec-edgar","filing":"0001517026-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702619000002/edgardoc.xml","form_type":"4"}},{"id":3406015,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Assurex Health Inc."}}],"security":"Common Stock","published_at":"2019-09-26T21:06:44.000Z","date":"2019-09-25","kind":"disposition_to_issuer","acquired":false,"shares":2897,"price":29.93,"value":86707.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":82681,"source":{"system":"sec-edgar","filing":"0001517026-19-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702619000002/edgardoc.xml","form_type":"4"}},{"id":3803018,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Assurex Health Inc."}}],"security":"Common Stock","published_at":"2018-10-02T13:16:10.000Z","date":"2018-09-30","kind":"disposition_to_issuer","acquired":false,"shares":725,"price":46,"value":33350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":85578,"source":{"system":"sec-edgar","filing":"0001517026-18-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702618000006/edgardoc.xml","form_type":"4"}},{"id":3807846,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Assurex Health Inc."}}],"security":"Common Stock","published_at":"2018-09-26T18:33:57.000Z","date":"2018-09-25","kind":"disposition_to_issuer","acquired":false,"shares":2897,"price":46.65,"value":135145.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":86303,"source":{"system":"sec-edgar","filing":"0001517026-18-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702618000004/edgardoc.xml","form_type":"4"}},{"id":3810152,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Assurex Health Inc."}}],"security":"Common Stock","published_at":"2018-09-21T16:19:11.000Z","date":"2018-09-19","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2019, 25% on September 25, 2020, 25% on September 25, 2021, and 25% on September 25, 2022."}],"balance_after":89200,"source":{"system":"sec-edgar","filing":"0001517026-18-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702618000002/edgardoc.xml","form_type":"4"}},{"id":4196101,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Assurex Health Inc."}}],"security":"Common Stock","published_at":"2017-10-03T20:45:25.000Z","date":"2017-09-30","kind":"disposition_to_issuer","acquired":false,"shares":800,"price":36.18,"value":28944.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person."}],"balance_after":49200,"source":{"system":"sec-edgar","filing":"0001517026-17-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702617000009/edgardoc.xml","form_type":"4"}},{"id":4208756,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52469,"kind":"person","name":"Verratti Mark","position":1,"cik":"0001517026","reported_name":"Verratti Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President Assurex Health Inc."}}],"security":"Common Stock","published_at":"2017-09-15T20:58:15.000Z","date":"2017-09-13","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 25, 2018, 25% on September 25, 2019, 25% on September 25, 2020, and 25% on September 25, 2021."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001517026-17-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000151702617000007/edgardoc.xml","form_type":"4"}}]}